Common use of Representative’s Warrant Clause in Contracts

Representative’s Warrant. The Company hereby agrees to issue to the Representative (and/or its designees) on the (i) First Closing Date, warrants to purchase such number of Ordinary Shares equal to ten percent (10%) of the Firm Shares issued on the First Closing Date and (ii) on each Option Closing Date, if and as applicable, warrants to purchase such number of Ordinary Shares equal to ten percent (10%) of the Option Shares issued at such Option Closing Date, if and as applicable (collectively, the “Representative’s Warrants”). The Representative’s Warrant may be exercised by the payment of cash or via cashless exercise, shall be exercisable for a period of five years from the Effective Date (as defined below) of the Registration Statement (as defined below) and will terminate on the fifth anniversary of the Effective Date of the Registration Statement. The exercise price of the Representative’s Warrant is equal to one hundred and twenty five percent (125%) of the public offering price of a Security. The Representative’s Warrant and the Ordinary Shares issuable upon exercise of the Representative’s Warrant will be deemed compensation by FINRA (as defined below), and therefore will be subject to FINRA Rule 5110(g)(1). In accordance with FINRA Rule 5110(e)(1), neither the Representative’s Warrant nor any of the Ordinary Shares issued upon exercise of the Representative’s Warrant may be sold, transferred, assigned, pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition of such securities by any person, for a period of one hundred and eighty (180) days beginning on the Effective Date, subject to certain exceptions as set forth in FINRA Rule 5110(e)(2).

Representative’s Warrant. The Company hereby agrees to issue to the Representative (and/or its designees) on the (i) First Closing Date, Date warrants to purchase such number of Ordinary Shares equal to ten percent (10%) percent of the Firm Shares issued on at the First Closing Date and (ii) on each Option Closing Date, if and as applicable, warrants to purchase such number of Ordinary Shares equal to ten percent (10%) of the Option Shares issued at such Option Closing Date, if and as applicable (collectively, the “Representative’s WarrantsWarrant”). The Representative’s Warrant may be exercised by the payment of cash or via cashless exercise, shall be exercisable for a period of five years from the Effective Date (as defined below) of the Registration Statement (as defined below) and will terminate on the fifth anniversary of the Effective Date of the Registration Statement. The exercise price of the Representative’s Warrant is equal to one hundred and twenty five ten (110) percent (125%) of the public offering price of a SecurityFirm Share. The Representative’s Warrant and the Ordinary Shares issuable upon exercise of the Representative’s Warrant will be deemed compensation by FINRA (as defined below)FINRA, and therefore will be subject to FINRA Rule 5110(g)(1). In accordance with FINRA Rule 5110(e)(15110(g)(1), neither the Representative’s Warrant nor any of the Ordinary Shares issued upon exercise of the Representative’s Warrant may be sold, transferred, assigned, pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition of such securities by any person, for a period of one hundred and eighty (180) 180 days beginning on immediately following the Effective Datedate of effectiveness of the Registration Statement pursuant to which the Representative’s Warrant is being issued, subject to certain exceptions as set forth in FINRA Rule 5110(e)(2)exceptions.

Representative’s Warrant. The Company hereby agrees to issue to the Representative (and/or its designees) on the (i) First Closing Date, warrants to purchase such number of Ordinary Shares equal to ten percent (10%) percent of the Firm Shares issued on the First at such and Closing Date and (ii) on each Option the Second Closing Date, if and as applicable, warrants to purchase such number of Ordinary Shares equal to ten percent (10%) of the Option Shares issued at such Option Closing DateClosing, if and as applicable (collectively, the “Representative’s Warrants”). The Representative’s Warrant may be exercised by the payment of cash or via cashless exercise, shall be exercisable for a period of five years from the Effective Date (as defined below) of the Registration Statement (as defined below) and will terminate on the fifth anniversary of the Effective Date of the Registration Statement. The exercise price of the Representative’s Warrant is equal to one hundred and twenty five ten (110) percent (125%) of the public offering price of a Security. The Representative’s Warrant and the Ordinary Shares issuable upon exercise of the Representative’s Warrant will be deemed compensation by FINRA (as defined below), and therefore will be subject to FINRA Rule 5110(g)(1). In accordance with FINRA Rule 5110(e)(1), neither the Representative’s Warrant nor any of the Ordinary Shares issued upon exercise of the Representative’s Warrant may be sold, transferred, assigned, pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition of such securities by any person, for a period of one hundred and eighty nine (1809) days months beginning on the Effective Datedate of commencement of sales of the Offering, subject to certain exceptions as set forth in FINRA Rule 5110(e)(2).

Representative’s Warrant. The Company hereby agrees to issue to the Representative (and/or its designees) on the (i) First Closing Date, Date warrants to purchase such number of Ordinary Shares common shares equal to ten eight percent (10%) of the Firm Shares issued on at the First Closing Date and (ii) on each Option Closing Date, if and as applicable, warrants to purchase such number of Ordinary Shares equal to ten percent (10%) of the Option Shares issued at such Option Closing Date, if and as applicable (collectively, the “Representative’s WarrantsWarrant”). The Representative’s Warrant may be exercised by the payment of purchased in cash or via cashless exercise, shall be exercisable for a period of five years from the Effective Date (as defined below) of the Registration Statement (as defined below) and will terminate on the fifth anniversary of the Effective Date of the Registration Statement. The exercise price of the Representative’s Warrant is equal to one hundred and twenty five percent (125%) of the price of the public offering price of a SecurityFirm Share. The Representative’s Warrant and the Ordinary Shares common shares issuable upon exercise of the Representative’s Warrant will be deemed compensation by FINRA (as defined below)FINRA, and therefore will be subject to FINRA Rule 5110(g)(1). In accordance with FINRA Rule 5110(e)(15110(g)(1), neither the Representative’s Warrant nor any of the Ordinary Shares issued upon exercise of the Representative’s Warrant may be sold, transferred, assigned, pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition of such securities by any person, for a period of one hundred and eighty (180) 180 days beginning on immediately following the Effective Datedate of effectiveness of the Registration Statement pursuant to which the Representative’s Warrant is being issued, subject to certain exceptions as set forth in FINRA Rule 5110(e)(2)exceptions.

Representative’s Warrant. The Company hereby agrees to issue to the Representative (and/or its designees) on the (i) First Closing Date, Date warrants to purchase such number of Ordinary Shares equal to ten percent (10%) of the Firm Shares issued on at the First Closing Date and (ii) on each Option Closing Date, if and as applicable, warrants to purchase such number of Ordinary Shares equal to ten percent (10%) of the Option Shares issued at such Option Closing Date, if and as applicable (collectively, the “Representative’s WarrantsWarrant”). The Representative’s Warrant may be exercised by the payment of purchased in cash or via cashless exercise, shall be exercisable for a period of five years from the Effective Date (as defined below) of the Registration Statement (as defined below) and will terminate on the fifth anniversary of the Effective Date of the Registration Statement. The exercise price of the Representative’s Warrant is equal to one hundred and twenty five fifteen percent (125%) of the price of the initial public offering price of a SecurityFirm Share. The Representative’s Warrant and the Ordinary Shares issuable upon exercise of the Representative’s Warrant will be deemed compensation by FINRA (as defined below)FINRA, and therefore will be subject to FINRA Rule 5110(g)(1). In accordance with FINRA Rule 5110(e)(15110(g)(1), neither the Representative’s Warrant nor any of the Ordinary Shares issued upon exercise of the Representative’s Warrant may be sold, transferred, assigned, pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition of such securities by any person, for a period of one hundred and eighty (180) 180 days beginning on immediately following the Effective Datedate of effectiveness of the Registration Statement pursuant to which the Representative’s Warrant is being issued, subject to certain exceptions as set forth in FINRA Rule 5110(e)(2)exceptions.

Representative’s Warrant. The Company hereby agrees to issue to the Representative (and/or its designees) on the (i) First Closing Date, Date warrants to purchase such number of Ordinary Shares equal to ten percent (10%) of the Firm Shares issued on at the First Closing Date and (ii) on each Option Closing Date, if and as applicable, warrants to purchase such number of Ordinary Shares equal to ten percent (10%) of the Option Shares issued at such Option Closing Date, if and as applicable (collectively, the “Representative’s WarrantsWarrant”). The Representative’s Warrant may be exercised by the payment of purchased in cash or via cashless exercise, shall be exercisable for a period of five years from the Effective Date (as defined below) of the Registration Statement (as defined below) and will terminate on the fifth anniversary of the Effective Date of the Registration Statement. The exercise price of the Representative’s Warrant is equal to one hundred and twenty five percent (125%) of the price of the initial public offering price of a SecurityFirm Share. The Representative’s Warrant and the Ordinary Shares issuable upon exercise of the Representative’s Warrant will be deemed compensation by FINRA (as defined below)FINRA, and therefore will be subject to FINRA Rule 5110(g)(1). In accordance with FINRA Rule 5110(e)(15110(g)(1), neither the Representative’s Warrant nor any of the Ordinary Shares issued upon exercise of the Representative’s Warrant may be sold, transferred, assigned, pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition of such securities by any person, for a period of one hundred and eighty (180) 180 days beginning on immediately following the Effective Datedate of effectiveness of the Registration Statement pursuant to which the Representative’s Warrant is being issued, subject to certain exceptions as set forth in FINRA Rule 5110(e)(2)exceptions.